These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 7522959

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Effects of mitogens on androgen receptor-mediated transactivation.
    Reinikainen P, Palvimo JJ, Jänne OA.
    Endocrinology; 1996 Oct; 137(10):4351-7. PubMed ID: 8828495
    [Abstract] [Full Text] [Related]

  • 43. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
    Mashima T, Okabe S, Seimiya H.
    Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
    [Abstract] [Full Text] [Related]

  • 44. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
    Godoy-Tundidor S, Hobisch A, Pfeil K, Bartsch G, Culig Z.
    Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
    [Abstract] [Full Text] [Related]

  • 45. Activation of the androgen receptor by polypeptide growth factors and cellular regulators.
    Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H.
    World J Urol; 1995 Jul; 13(5):285-9. PubMed ID: 8580999
    [Abstract] [Full Text] [Related]

  • 46. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
    Lu Y, Feng F, Yang Y, Gao X, Cui J, Zhang C, Zhang F, Xu Z, Qv J, Wang C, Zeng Z, Zhu Y, Yang Y.
    Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
    [Abstract] [Full Text] [Related]

  • 47. Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell lines.
    Kawabata R, Oie S, Takahashi M, Kanayama H, Oka T, Itoh K.
    Int J Oncol; 2011 Jun; 38(6):1489-500. PubMed ID: 21455575
    [Abstract] [Full Text] [Related]

  • 48. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element.
    Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J.
    Mol Endocrinol; 1991 Dec; 5(12):1921-30. PubMed ID: 1724287
    [Abstract] [Full Text] [Related]

  • 49. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells.
    Makkonen H, Kauhanen M, Jääskeläinen T, Palvimo JJ.
    Mol Cell Endocrinol; 2011 Jan 01; 331(1):57-65. PubMed ID: 20728506
    [Abstract] [Full Text] [Related]

  • 50. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H, Arai S, Nakagawa T, Ishikura N, Nishimoto A, Yoshino H, Shiraishi T, Tachibana K, Nakamura R, Sato H.
    Prostate; 2011 Sep 01; 71(12):1344-56. PubMed ID: 21308717
    [Abstract] [Full Text] [Related]

  • 51. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
    Abdelbaqi K, Lack N, Guns ET, Kotha L, Safe S, Sanderson JT.
    Prostate; 2011 Sep 15; 71(13):1401-12. PubMed ID: 21321979
    [Abstract] [Full Text] [Related]

  • 52. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B, Yeung F, Konaka H, Mayo MW, Freeman MR, Zhau HE, Chung LW.
    Biochem J; 2004 Apr 15; 379(Pt 2):421-31. PubMed ID: 14715080
    [Abstract] [Full Text] [Related]

  • 53. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P, Bonaccorsi L, Baldi E, Chiasserini C, Forti G, De Chiara G, Lucibello M, Mongiat M, Iozzo RV, Garaci E, Cozzolino F, Torcia MG.
    Prostate; 2002 Dec 01; 53(4):310-21. PubMed ID: 12430142
    [Abstract] [Full Text] [Related]

  • 54. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator.
    Dotan N, Wasser SP, Mahajna J.
    Integr Cancer Ther; 2011 Jun 01; 10(2):148-59. PubMed ID: 21147815
    [Abstract] [Full Text] [Related]

  • 55. Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.
    Orio F, Térouanne B, Georget V, Lumbroso S, Avances C, Siatka C, Sultan C.
    Mol Cell Endocrinol; 2002 Dec 30; 198(1-2):105-14. PubMed ID: 12573820
    [Abstract] [Full Text] [Related]

  • 56. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1997 Aug 30; 138(8):3290-8. PubMed ID: 9231780
    [Abstract] [Full Text] [Related]

  • 57. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y, Liu G, Tong D, Parmar H, Hasenmayer D, Yuan W, Zhang D, Jiang J.
    Prostate; 2015 Aug 01; 75(11):1187-96. PubMed ID: 25894097
    [Abstract] [Full Text] [Related]

  • 58. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S.
    Prostate; 2005 Dec 01; 65(4):287-98. PubMed ID: 16015608
    [Abstract] [Full Text] [Related]

  • 59. A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
    Krishnan AV, Zhao XY, Swami S, Brive L, Peehl DM, Ely KR, Feldman D.
    Endocrinology; 2002 May 01; 143(5):1889-900. PubMed ID: 11956172
    [Abstract] [Full Text] [Related]

  • 60. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
    Lin DL, Whitney MC, Yao Z, Keller ET.
    Clin Cancer Res; 2001 Jun 01; 7(6):1773-81. PubMed ID: 11410519
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.